X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4673) 4673
Publication (644) 644
Patent (139) 139
Conference Proceeding (121) 121
Book / eBook (98) 98
Book Chapter (56) 56
Book Review (34) 34
Paper (24) 24
Magazine Article (20) 20
Dissertation (18) 18
Report (15) 15
Newspaper Article (14) 14
Web Resource (9) 9
Trade Publication Article (4) 4
Technical Report (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1162) 1162
male (775) 775
index medicus (727) 727
female (714) 714
middle aged (458) 458
adult (431) 431
animals (417) 417
aged (374) 374
analysis (240) 240
astronomy & astrophysics (160) 160
rats (154) 154
astrophysics (145) 145
aged, 80 and over (144) 144
adolescent (139) 139
general relativity and quantum cosmology (135) 135
biochemistry & molecular biology (134) 134
neurosciences (134) 134
child (127) 127
research (127) 127
physics (126) 126
surgery (122) 122
medicine & public health (114) 114
risk factors (111) 111
pharmacology & pharmacy (108) 108
high energy astrophysical phenomena (107) 107
physics, particles & fields (106) 106
public, environmental & occupational health (102) 102
mice (101) 101
treatment outcome (98) 98
chemistry, physical (97) 97
cardiac & cardiovascular systems (94) 94
immunology (92) 92
astrophysics - high energy astrophysical phenomena (90) 90
italy (89) 89
dermatology (87) 87
diagnosis (87) 87
time factors (86) 86
health aspects (85) 85
young adult (83) 83
oncology (82) 82
chemistry (79) 79
disease (79) 79
prevalence (79) 79
endocrinology & metabolism (76) 76
care and treatment (75) 75
proteins (75) 75
cancer (74) 74
prospective studies (74) 74
retrospective studies (74) 74
management (73) 73
mortality (72) 72
in vitro techniques (71) 71
polymer science (71) 71
studies (71) 71
child, preschool (70) 70
physics, multidisciplinary (70) 70
children (67) 67
materials science, multidisciplinary (65) 65
physiological aspects (62) 62
chemistry, organic (60) 60
kinetics (60) 60
patients (60) 60
chemistry, multidisciplinary (59) 59
hematology (59) 59
life sciences (59) 59
rabbits (59) 59
expression (58) 58
pathology (58) 58
risk (58) 58
usage (58) 58
microbiology (57) 57
mutation (57) 57
agronomy (56) 56
clinical neurology (56) 56
environmental sciences (56) 56
follow-up studies (56) 56
infant (56) 56
medicine (56) 56
skin (55) 55
abridged index medicus (54) 54
cross-sectional studies (54) 54
epidemiology (54) 54
high energy physics - theory (54) 54
mathematics (54) 54
physics, applied (54) 54
agriculture (53) 53
dna (53) 53
orthopedics (53) 53
pediatrics (53) 53
cell biology (52) 52
immunohistochemistry (52) 52
mathematical models (52) 52
performing operations (51) 51
transporting (51) 51
population (49) 49
pregnancy (49) 49
evolution (48) 48
growth (48) 48
multidisciplinary sciences (48) 48
biochemistry (47) 47
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (49) 49
UTL at Downsview - May be requested (18) 18
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Gerstein Science - Stacks (7) 7
Art - Library use only (5) 5
Pontifical Inst. Mediaeval Studies - Library use only (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Music - Stacks (3) 3
Online Resources - Online (3) 3
UofT at Mississauga - Stacks (3) 3
Victoria University CRRS - Library use only (3) 3
Thomas Fisher Rare Book - Rare Book (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gardiner Museum - Library use only (1) 1
Institute for Christian Studies - Stacks (1) 1
Media Commons - Microtexts (1) 1
Robarts - Searching (1) 1
Royal Ontario Museum - Archives (1) 1
Royal Ontario Museum - Far Eastern (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Thomas Fisher Rare Book - Reference (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4337) 4337
Italian (369) 369
French (207) 207
Portuguese (181) 181
Spanish (68) 68
German (39) 39
Japanese (6) 6
Chinese (5) 5
Latin (5) 5
Romanian (5) 5
Ancient Greek (2) 2
Norwegian (2) 2
Polish (2) 2
Swedish (2) 2
Danish (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


INFLUENCIA DE LA FECHA DE SIEMBRA Y DE LA PROCEDENCIA DE LA SEMILLA EN EL RENDIMIENTO DE CAPÍTULOS DE Calendula officinalis L., DURANTE DOS TEMPORADAS EN CHILLÁN (Influence of sowing date and seed origin on the yield of capitula of Calendula officinalis L. during two growing seasons in Chillán), 01/2003
Calendula or the pot marigold (Calendula officinalis L.) is a plant whose dried flower heads are used to heal wounds and are marketed as dried capitula or... 
Plant Sciences
Journal
British Journal of Pharmacology, ISSN 0007-1188, 03/2007, Volume 150, Issue 5, pp. 567 - 576
Background and purpose: Phosphodiesterase‐5 inhibitors are beneficial in pulmonary hypertension and congestive heart failure, the two conditions associated... 
L‐NAME‐induced hypertension | myocardial ischaemia–reperfusion | sildenafil | L-NAME-induced hypertension | Myocardial ischaemia-reperfusion | Sildenafil | ORAL SILDENAFIL | NITRIC-OXIDE SYNTHASE | HEART-FAILURE | CARDIAC MYOCYTES | MODEL | TREATED RATS | ARTERIAL-HYPERTENSION | PHARMACOLOGY & PHARMACY | PHOSPHODIESTERASE-5 INHIBITION | VENTRICULAR DYSFUNCTION | myocardial ischaemia-reperfusion | ERECTILE DYSFUNCTION | Phosphodiesterase Inhibitors - therapeutic use | Sulfones - therapeutic use | Antihypertensive Agents - pharmacology | Enzyme Inhibitors | Biomarkers - urine | Rats, Wistar | Vasodilator Agents - therapeutic use | Myocardial Reperfusion Injury - chemically induced | Nitric Oxide Synthase - antagonists & inhibitors | Endothelium, Vascular - drug effects | Male | Sulfones - pharmacology | Dose-Response Relationship, Drug | Sildenafil Citrate | Heart Rate - drug effects | Time Factors | Hypertension - chemically induced | Hypertension - prevention & control | Blood Pressure - drug effects | Purines - therapeutic use | Disease Models, Animal | Ventricular Function - drug effects | Severity of Illness Index | Vasodilator Agents - pharmacology | Purines - pharmacology | NG-Nitroarginine Methyl Ester | Phosphodiesterase Inhibitors - pharmacology | Rats | Piperazines - therapeutic use | Antihypertensive Agents - therapeutic use | Piperazines - pharmacology | Hypertension - physiopathology | Myocardial Reperfusion Injury - physiopathology | Cardiovascular Agents - pharmacology | Hypertension - metabolism | Myocardial Reperfusion Injury - metabolism | Animals | Cyclic GMP - metabolism | Nitric Oxide Synthase - metabolism | Vasodilation - drug effects | Myocardial Reperfusion Injury - prevention & control | Research Papers
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Life Sciences | Human health and pathology | Cardiology and cardiovascular system | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article